Toxic shock syndrome: Difference between revisions

No edit summary
Line 1: Line 1:
==Background==
==Background==
===Epidemiology===
*1-2/100,000 cases/year
1-2/100,000 cases/year
*[[S. aureus]] strain that produces toxic shock syndrome toxin-1 (superantigen) is the most common cause
 
===Etiology===
*[[S. aureus]] strain that produces toxic shock syndrome toxin-1 (superantigen)
**GAS is a less common cause
**GAS is a less common cause
*Superantigens stimulate T-cell proliferation independent of antigen-specific binding --> massive cytokine production
*Superantigens stimulate T-cell proliferation independent of antigen-specific binding --> massive cytokine production
*Also effect neutrophil chemotaxis suppression, blockage of reticuloendothelial system
**Also affect neutrophil chemotaxis suppression and blockage of reticuloendothelial system


===Risk Factors===
===Risk Factors===
*postop patients
*Postop patients
*[[Epistaxis|nasal packing]]
*[[Epistaxis|nasal packing]]
*abscess
*Abscess
*burns
*Burns
*tampons
*Tampon use
*IUDs
*IUDs


===Clinical Features===
==Clinical Features<ref name="CDC">CDC. Toxic Shock Syndrome (Other Than Streptococcal). 2011</ref>==
<ref name="CDC">CDC. Toxic Shock Syndrome (Other Than Streptococcal). 2011</ref>
*[[Fever]]: temperature >38.9°C
*[[Fever]]: temperature >38.9°C
*[[Rash]]: diffuse macular erythroderma
*[[Rash]]: diffuse macular erythroderma
Line 39: Line 35:
**Negative culture results for blood, or cerebrospinal fluid (blood may be positive for S. aureus)
**Negative culture results for blood, or cerebrospinal fluid (blood may be positive for S. aureus)
**Absence of an increase in antibody titers to the agents of [[leptospirosis]], [[measles]], or [[Rocky mountain spotted fever]].
**Absence of an increase in antibody titers to the agents of [[leptospirosis]], [[measles]], or [[Rocky mountain spotted fever]].
*Confirmed case meets all 5 clinical criteria ( [[Clinical Features]] ) plus lab criteria  
*Confirmed case meets all 5 clinical criteria ( [[Clinical Features]] ) plus lab criteria  
*Probable case meets 4-5 clinical criteria plus lab criteria
*Probable case meets 4-5 clinical criteria plus lab criteria
Line 52: Line 47:
==References==
==References==
<references/>
<references/>
AnnalsofEM Nov 2009


[[Category:ID]]
[[Category:ID]]

Revision as of 16:46, 8 February 2017

Background

  • 1-2/100,000 cases/year
  • S. aureus strain that produces toxic shock syndrome toxin-1 (superantigen) is the most common cause
    • GAS is a less common cause
  • Superantigens stimulate T-cell proliferation independent of antigen-specific binding --> massive cytokine production
    • Also affect neutrophil chemotaxis suppression and blockage of reticuloendothelial system

Risk Factors

Clinical Features[1]

  • Fever: temperature >38.9°C
  • Rash: diffuse macular erythroderma
  • Hypotension: systolic blood pressure <90 mm Hg (adults) or <5th percentile for age (children younger than 16 years), or orthostatic hypotension, dizziness, or syncope
  • Multisystem dysfunction: at least 3:
    • Gastrointestinal: vomiting or diarrhea at onset of illness
    • Muscular: severe myalgias, or serum creatine phosphokinase level (CPK) greater than twice the upper limit of normal
    • Mucous membranes: vaginal, oropharyngeal, or conjunctival hyperemia
    • Renal: blood urea nitrogen or creatinine level greater than twice the upper limit of normal, or pyuria (5 leukocytes per high-power field), in the absence of urinary tract infection
    • Hepatic: total serum bilirubin or transaminase level greater than twice the upper limit of normal
    • Hematologic: platelets<100,000/L
    • Central nervous system: disorientation or alteration in consciousness but no focal neurologic signs at a time when fever and hypotension are absent.
  • Desquamation: One to 2 weeks after the onset of illness (typically palms and soles)

Differential Diagnosis

Erythematous rash

Evaluation

  • Lab Criteria for Diagnosis (if obtained)[1]:
  • Confirmed case meets all 5 clinical criteria ( Clinical Features ) plus lab criteria
  • Probable case meets 4-5 clinical criteria plus lab criteria

Management

  • Antibiotics: Clindamycin (suppresses toxin synthesis), plus an anti-staph penicillin (Oxacillin or Nafcillin) or Vanc
  • Supportive, pressors often

Disposition

  • Admit

References

  1. 1.0 1.1 CDC. Toxic Shock Syndrome (Other Than Streptococcal). 2011